Essex Woodlands Management’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-10,483
| Closed | -$140K | – | 8 |
|
2022
Q2 | $140K | Hold |
10,483
| – | – | 0.06% | 9 |
|
2022
Q1 | $52K | Hold |
10,483
| – | – | 0.01% | 9 |
|
2021
Q4 | $72K | Hold |
10,483
| – | – | 0.02% | 10 |
|
2021
Q3 | $323K | Hold |
10,483
| – | – | 0.07% | 9 |
|
2021
Q2 | $340K | Hold |
10,483
| – | – | 0.05% | 9 |
|
2021
Q1 | $396K | Hold |
10,483
| – | – | 0.06% | 9 |
|
2020
Q4 | $496K | Hold |
10,483
| – | – | 0.13% | 8 |
|
2020
Q3 | $338K | Hold |
10,483
| – | – | 0.18% | 7 |
|
2020
Q2 | $462K | Hold |
10,483
| – | – | 0.23% | 7 |
|
2020
Q1 | $344K | Hold |
10,483
| – | – | 0.22% | 7 |
|
2019
Q4 | $535K | Hold |
10,483
| – | – | 0.25% | 8 |
|
2019
Q3 | $386K | Hold |
10,483
| – | – | 0.24% | 6 |
|
2019
Q2 | $579K | Hold |
10,483
| – | – | 0.33% | 6 |
|
2019
Q1 | $640K | Hold |
10,483
| – | – | 0.32% | 7 |
|
2018
Q4 | $625K | Hold |
10,483
| – | – | 0.25% | 7 |
|
2018
Q3 | $861K | Hold |
10,483
| – | – | 0.18% | 7 |
|
2018
Q2 | $933K | Hold |
10,483
| – | – | 0.22% | 7 |
|
2018
Q1 | $2.11M | Hold |
10,483
| – | – | 0.46% | 8 |
|
2017
Q4 | $1.09M | Hold |
10,483
| – | – | 0.2% | 8 |
|
2017
Q3 | $404K | Hold |
10,483
| – | – | 0.07% | 9 |
|
2017
Q2 | $372K | Hold |
10,483
| – | – | 0.07% | 9 |
|
2017
Q1 | $757K | Hold |
10,483
| – | – | 0.17% | 10 |
|
2016
Q4 | $778K | Hold |
10,483
| – | – | 0.18% | 10 |
|
2016
Q3 | $1.45M | Hold |
10,483
| – | – | 0.3% | 10 |
|
2016
Q2 | $1.82M | Hold |
10,483
| – | – | 0.46% | 10 |
|
2016
Q1 | $2.02M | Hold |
10,483
| – | – | 0.53% | 9 |
|
2015
Q4 | $3.78M | Hold |
10,483
| – | – | 0.69% | 9 |
|
2015
Q3 | $5.66M | Buy |
+10,483
| New | +$5.66M | 1.03% | 7 |
|